Sample Receiving Technician, Environment Testing
also has a rapidly developing presence in highly specialised and molecular clinical diagnostic testing and in-vitro diagnostic products...
also has a rapidly developing presence in highly specialised and molecular clinical diagnostic testing and in-vitro diagnostic products...
testing and in-vitro diagnostic products. In over 35 years, Eurofins has grown from one laboratory in Nantes, France...
in vitro and in vivo assay development. Extensive scientific knowledge of metabolic diseases and mechanisms of body weight... Significant experience with in vitro, in vivo, and ex vivo technologies to assess multiple target classes. Ability to manage...
employs in vitro, rodent, and non-rodent models, this role will focus primarily on non-rodent translational models. The...
presence in highly specialised and molecular clinical diagnostic testing and in-vitro diagnostic products. In over 35 years...
also has a rapidly developing presence in highly specialised and molecular clinical diagnostic testing and in-vitro diagnostic products... and in-vitro diagnostic products. In over 30 years, Eurofins has grown from one laboratory in Nantes, France to 58,000 staff...
also has a rapidly developing presence in highly specialised and molecular clinical diagnostic testing and in-vitro diagnostic products... and molecular clinical diagnostic testing and in-vitro diagnostic products. In over 30 years, Eurofins has grown...
also has a rapidly developing presence in highly specialised and molecular clinical diagnostic testing and in-vitro diagnostic products... presence in highly specialised and molecular clinical diagnostic testing and in-vitro diagnostic products. In over 30 years...
. Performs semi-in-vitro studies in wet lab. Takes call and performs emergent studies when necessary. Utilizes radiology...
The Opportunity Imaging-based phenotyping of in vitro biology is at the heart of insitro's efforts to accelerate drug... from disease-relevant in vitro models to identify potential therapeutic targets from perturbation screens Partner...